Loading organizations...
Loading organizations...
Biopharmaceutical company offering gene transfer and editing therapies.
AavantiBio has raised $107.0M across 1 funding round.
AavantiBio has raised $107.0M in total across 1 funding round.
AavantiBio has raised $107.0M in total across 1 funding round.
AavantiBio's investors include Bain Capital Life Sciences, Perceptive Advisors, RA Capital Management, Louise Rodino-Klapac.
AavantiBio has raised $107.0M across 1 funding round. Most recently, it raised $107.0M Series A in October 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 22, 2020 | $107.0M Series A | Bain Capital Life Sciences, Perceptive Advisors, RA Capital Management, Louise Rodino-Klapac |